Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LENSAR, Inc. stock logo
LNSR
LENSAR
$13.10
-0.7%
$13.19
$3.50
$17.31
$154.45M0.593,387 shs28,531 shs
Nephros Inc. stock logo
NEPH
Nephros
$3.64
+1.7%
$3.37
$1.36
$5.00
$38.58M1.0918,587 shs21,142 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.19
-2.3%
$43.50
$17.81
$70.26
$150.58M0.1937,896 shs24,867 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$5.17
-4.8%
$5.82
$4.71
$14.16
$136.64M1.52192,818 shs434,385 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LENSAR, Inc. stock logo
LNSR
LENSAR
+0.38%+0.61%+7.32%-5.18%+148.40%
Nephros Inc. stock logo
NEPH
Nephros
+3.77%-4.53%-5.29%+82.75%+65.74%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.55%-1.03%+10.88%-22.29%+137.54%
Avita Medical Inc. stock logo
RCEL
Avita Medical
+1.88%-8.59%+4.22%-41.04%-46.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LENSAR, Inc. stock logo
LNSR
LENSAR
1.2004 of 5 stars
2.02.00.00.02.72.50.0
Nephros Inc. stock logo
NEPH
Nephros
2.8037 of 5 stars
3.55.00.00.02.70.80.0
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2.1944 of 5 stars
2.52.00.00.02.21.71.9
Avita Medical Inc. stock logo
RCEL
Avita Medical
1.3795 of 5 stars
3.40.00.00.02.70.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LENSAR, Inc. stock logo
LNSR
LENSAR
2.00
Hold$15.0014.50% Upside
Nephros Inc. stock logo
NEPH
Nephros
3.00
Buy$5.0037.36% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
3.00
Buy$56.0021.24% Upside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.75
Moderate Buy$16.50219.15% Upside

Current Analyst Ratings Breakdown

Latest NEPH, RCEL, LNSR, and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00
5/27/2025
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$54.00 ➝ $56.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LENSAR, Inc. stock logo
LNSR
LENSAR
$53.49M2.89N/AN/A$0.42 per share31.19
Nephros Inc. stock logo
NEPH
Nephros
$14.16M2.72$0.02 per share172.41$0.81 per share4.49
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$53.84M2.80$0.93 per share49.64$9.03 per share5.12
Avita Medical Inc. stock logo
RCEL
Avita Medical
$64.25M2.13N/AN/A$0.17 per share30.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LENSAR, Inc. stock logo
LNSR
LENSAR
-$31.40M-$4.85N/AN/A-99.17%-737.30%-81.69%8/14/2025 (Estimated)
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.0752.01N/A5.16%9.43%7.20%8/6/2025 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$2.13M$2.8016.5022.42N/A14.61%29.08%16.19%9/4/2025 (Estimated)
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$61.85M-$2.19N/AN/AN/A-79.61%-632.62%-71.72%8/6/2025 (Estimated)

Latest NEPH, RCEL, LNSR, and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.26N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million
5/8/2025Q1 2025
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.1550-$2.32-$2.1650-$2.32$13.40 million$11.53 million
5/8/2025Q1 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.39-$0.53-$0.14-$0.53$33.15 million$18.51 million
5/1/2025Q3 2025
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.47$0.98+$0.51$0.98$17.70 million$17.41 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
1.81
1.25
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.92
4.64
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.28
2.73
1.45
Avita Medical Inc. stock logo
RCEL
Avita Medical
9.39
2.09
1.72

Institutional Ownership

CompanyInstitutional Ownership
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%

Insider Ownership

CompanyInsider Ownership
LENSAR, Inc. stock logo
LNSR
LENSAR
38.52%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
47.50%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
LENSAR, Inc. stock logo
LNSR
LENSAR
11011.79 million7.25 millionOptionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1403.26 million1.71 millionNot Optionable
Avita Medical Inc. stock logo
RCEL
Avita Medical
13026.43 million25.70 millionOptionable

Recent News About These Companies

AVITA Medical, Inc. (RCEL) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
LENSAR stock logo

LENSAR NASDAQ:LNSR

$13.10 -0.09 (-0.68%)
Closing price 04:00 PM Eastern
Extended Trading
$13.10 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Nephros stock logo

Nephros NASDAQ:NEPH

$3.64 +0.06 (+1.68%)
Closing price 03:52 PM Eastern
Extended Trading
$3.64 +0.00 (+0.14%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$46.19 -1.08 (-2.28%)
Closing price 04:00 PM Eastern
Extended Trading
$46.10 -0.09 (-0.19%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$5.17 -0.26 (-4.79%)
Closing price 04:00 PM Eastern
Extended Trading
$5.30 +0.13 (+2.51%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.